RT Journal Article
SR Electronic
T1 Genetically influenced tobacco and alcohol use behaviors impact erythroid trait variation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.05.01.23289329
DO 10.1101/2023.05.01.23289329
A1 Shivakumar, Shriya
A1 Wilken, Madison B
A1 Tsao, Victor
A1 Bitarello, Bárbara D.
A1 Thom, Christopher S
YR 2023
UL http://medrxiv.org/content/early/2023/05/11/2023.05.01.23289329.abstract
AB Genome wide association studies (GWAS) have associated thousands of loci with quantitative human blood trait variation. Blood trait associated loci and related genes may regulate blood cell-intrinsic biological processes, or alternatively impact blood cell development and function via systemic factors and disease processes. Clinical observations linking behaviors like tobacco or alcohol use with altered blood traits can be subject to bias, and these trait relationships have not been systematically explored at the genetic level. Using a Mendelian randomization (MR) framework, we confirmed causal effects of smoking and drinking that were largely confined to the erythroid lineage. Using multivariable MR and causal mediation analyses, we confirmed that an increased genetic predisposition to smoke tobacco was associated with increased alcohol intake, indirectly decreasing red blood cell count and related erythroid traits. These findings demonstrate a novel role for genetically influenced behaviors in determining human blood traits, revealing opportunities to dissect related pathways and mechanisms that influence hematopoiesis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health (K99HL156052 to CST), University of Pennsylvania Undergraduate Translational Research Immersion Program (SS), and University of Pennsylvania Undergraduate Research Mentoring Program (VT).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used only publicly available GWAS summary statistics.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesCoding scripts and data sets, including full instrumental variables used in our study, can be found on Github (https://github.com/thomchr/SmkBloodMR) and are also available upon request.https://github.com/thomchr/SmkBloodMR